BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  American Society of Anesthesiologists Announces Collaboration With Digital Surgery™ to Deliver an Innovative Educational Activity in Neuromuscular Blockade Recovery

  Pathway allows ASA members to access academically validated, interactive training content on mobile app, and is part of a CME-accredited program for the entire care team

  February 4, 2019

   · 

  3 min read
• Business

  CollPlant Announces Appointment of Jonathan M.N. Rigby as Chairman of the Board

  CollPlant, a regenerative medicine company, announced that Jonathan M.N. Rigby has been appointed as Chairman of the Board of Directors effective immediately.

  February 4, 2019

   · 

  6 min read
• Business

  Clinical Innovations Hires Jason Whetstone as VP of Human Resources

  Experienced leader will strengthen company’s world-wide workforce

  February 4, 2019

   · 

  3 min read
• Business

  Lung Therapeutics, Inc. Announces New Chief Financial Officer and Board Member

  Lung Therapeutics, Inc. announced the hiring of Charles T. Garner as Chief Financial Officer and the appointment of R.A. Session, II, to the company’s Board of Directors.

  February 4, 2019

   · 

  3 min read
• Pharm Country

  Spectrum Chemical Mfg. Corporation Receives GE Distinguished Partner Award for Applied Markets for Second Consecutive Year

  Spectrum Chemical Mfg. Corp., a leading global manufacturer and distributor of fine chemicals, laboratory equipment and supplies, has been honored for the second year in a row with the Distinguished Partner Award for Applied Markets from GE Healthcare Life Sciences.

  February 4, 2019

   · 

  3 min read
• Business

  Alexion Reports Fourth Quarter and Full Year 2018 Results

  4Q18 total revenues of $1,128.8 million, a 24 percent increase over 4Q17 and a 30 percent volume increase

  February 4, 2019

   · 

  27 min read
• Drug Development

  Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis

  Eli Lilly and Company and Incyte Corporation announced today that baricitinib met the primary endpoint in BREEZE-AD1 and BREEZE-AD2, two Phase 3 studies evaluating the efficacy and safety of baricitinib monotherapy for the treatment of adult patients with moderate to severe atopic dermatitis.

  February 4, 2019

   · 

  13 min read
• Policy

  European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

  Recommendation Based on Significant Overall Survival Benefit Demonstrated with KEYTRUDA in Combination with Chemotherapy in Pivotal KEYNOTE-407 Trial

  February 4, 2019

   · 

  28 min read
• Deals

  Cibus Announces Launch of Initial Public Offering

  Cibus Global, Ltd. today announced the launch of its underwritten initial public offering of 6,666,667 shares of its Class A common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission.

  February 4, 2019

   · 

  3 min read
• Pharm Country

  CytoSorbents Announces the Data Safety Monitoring Board Recommends Continuation of REMOVE Endocarditis Trial

  CytoSorbents Corporation announced that the Data Safety Monitoring Board of the German government-funded REMOVE Endocarditis trial recommended continuation of the study following an interim analysis on the first 50 patients of the study.

  February 4, 2019

   · 

  6 min read